7-benzylidenenaltrexone and Diabetes-Mellitus

7-benzylidenenaltrexone has been researched along with Diabetes-Mellitus* in 1 studies

Other Studies

1 other study(ies) available for 7-benzylidenenaltrexone and Diabetes-Mellitus

Article	Year
Possible role of the phosphoinositide pathway for signal transduction in changes in the sensitivity of delta-opiate receptors during diabetes mellitus. Bulletin of experimental biology and medicine, 2004, Volume: 137, Issue:2 We studied the effects of selective delta-opiate receptor agonists and antagonists on the phosphoinositide pathway in lymphocytes from healthy donors and patients with diabetes mellitus. The test compounds probably play a role in changes in the sensitivity to pharmacological substances binding to delta-opiate receptors during diabetes mellitus. Topics: Benzylidene Compounds; Diabetes Mellitus; Diglycerides; Humans; In Vitro Techniques; Lymphocytes; Naltrexone; Oligopeptides; Phosphatidylinositols; Receptors, Opioid, delta; Signal Transduction	2004

Article

Year

Possible role of the phosphoinositide pathway for signal transduction in changes in the sensitivity of delta-opiate receptors during diabetes mellitus.

Bulletin of experimental biology and medicine, 2004, Volume: 137, Issue:2

We studied the effects of selective delta-opiate receptor agonists and antagonists on the phosphoinositide pathway in lymphocytes from healthy donors and patients with diabetes mellitus. The test compounds probably play a role in changes in the sensitivity to pharmacological substances binding to delta-opiate receptors during diabetes mellitus.

Topics: Benzylidene Compounds; Diabetes Mellitus; Diglycerides; Humans; In Vitro Techniques; Lymphocytes; Naltrexone; Oligopeptides; Phosphatidylinositols; Receptors, Opioid, delta; Signal Transduction

2004